MEDICINA
Departamento
University of Toronto
Toronto, CanadáPublicaciones en colaboración con investigadores/as de University of Toronto (24)
2022
-
Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction
European heart journal, Vol. 43, Núm. 7, pp. 641-650
2021
-
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
The Lancet Oncology, Vol. 22, Núm. 5, pp. 727-736
-
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
British Journal of Haematology, Vol. 194, Núm. 3, pp. 496-507
-
Safety and feasibility of mitraclip implantation in patients with acute mitral regurgitation after recent myocardial infarction and severe left ventricle dysfunction
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
-
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 6, pp. 1259-1267
2019
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973
-
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
The Lancet, Vol. 394, Núm. 10206, pp. 1325-1334
2018
-
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
The Lancet Haematology, Vol. 5, Núm. 11, pp. e563-e598
2017
-
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
American Heart Journal, Vol. 193, pp. 46-54
-
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
Haematologica, Vol. 102, Núm. 2, pp. 308-319
2015
-
Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis
Heart, Vol. 101, Núm. 19, pp. 1554-1561
-
Outcomes of estrogen receptor negative and progesterone receptor positive breast cancer
PLoS ONE, Vol. 10, Núm. 7
-
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: A patient-level analysis of the randomized early routine invasive clinical trials
JACC: Cardiovascular Interventions, Vol. 8, Núm. 1, pp. 166-174
2014
-
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes - Proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS
Leukemia, Vol. 28, Núm. 9, pp. 1793-1798
-
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3
2012
-
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection
PLoS ONE, Vol. 7, Núm. 6
2011
-
Inflammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity
PLoS Neglected Tropical Diseases, Vol. 5, Núm. 8
2010
-
Quality, quantity and harmony: The DataSHaPER approach to integrating data across bioclinical studies
International Journal of Epidemiology, Vol. 39, Núm. 5, pp. 1383-1393